SBIR

ALAMO, Calif., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Synergys Biotherapeutics, a preclinical stage biotherapeutics company developing Vasculogenic Mimicry (VM)-blocking antibody fusion drugs,…

HOUSTON, Aug. 01, 2022 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC (“7 Hills” or “7HP”), a clinical-stage pharma company developing a platform of first-in-class oral small molecules to enhance…

NORTON, Mass., June 07, 2022 (GLOBE NEWSWIRE) -- CPS Technologies Corporation (NASDAQ:CPSH) has been awarded a Small Business Innovation Research (SBIR) contract from the US Army -…

Quantum computing companies brought in new funding this month via two very different sources: a small business innovation grant and a special purpose acquisition company. The…

EDMONDS, Wash., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Jetoptera has been awarded a new Phase II SBIR sub-contract by Freedom Flight Works, Inc. to collaborate in the development of a special…

Houston, TX, Nov. 18, 2021 (GLOBE NEWSWIRE) -- RadioMedix, a clinical-stage biotechnology company developing radiotheranostic drugs, announced that it has been awarded a $2.0M Direct to…